3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
22
Melanoma
21
Carcinoma, Non-Small-Cell Lung
20
Neoplasms
8
Lung Neoplasms
8
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Neoplasm Metastasis
7
Stomach Neoplasms
6
Prostatic Neoplasms
6
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Adenocarcinoma Of Esophagus
6
Rectal Neoplasms
5
Hodgkin Disease
5
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Nasopharyngeal Carcinoma
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Recurrence
3
Oropharyngeal Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Hematologic Neoplasms
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Interventions
Bevacizumab
12
olaparib
11
Paclitaxel
11
Carboplatin
11
liposomal doxorubicin
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
6
Taxes
5
Immunoglobulin G
5
Disulfides
5
mirvetuximab soravtansine
4
cediranib
4
Topotecan
4
Gemcitabine
4
Biopsy
4
pembrolizumab
3
Oxaliplatin
2
Doxorubicin
2
1-dodecylpyridoxal
2
vistusertib
1
tremelimumab
1
trastuzumab deruxtecan
1
sotorasib
1
sarilumab
1
palbociclib
1
niraparib
1
nilotinib
1
neratinib
1
irinotecan sucrosofate
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Nivolumab
×
30 days
×
Clear all
No trials found.